CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $61,000 | -85.8% | 147,818 | -31.5% | 0.01% | -87.0% |
| Q3 2019 | $431,000 | -52.7% | 215,718 | -48.9% | 0.08% | -49.7% |
| Q2 2019 | $912,000 | -14.6% | 422,123 | +24.9% | 0.15% | -20.7% |
| Q1 2019 | $1,068,000 | +28.5% | 337,868 | +1.2% | 0.19% | +9.7% |
| Q4 2018 | $831,000 | -25.9% | 333,855 | +19.7% | 0.18% | +1.1% |
| Q3 2018 | $1,121,000 | – | 278,940 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|